Skip to main content
Figure 6 | Breast Cancer Research

Figure 6

From: A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

Figure 6

Kaplan-Meier estimates of disease-free survival for estrogen receptor-beta (ER-β) status within the molecular subtypes. Kaplan-Meier estimates of disease-free survival for estrogen receptor-beta (ER-β) status within the molecular subtypes and according to negative (N-) or positive (N+) nodal status, respectively, in each subgroup: luminal A (LA) (a, e), luminal B (LB) (b, f), HER2 (HS) (c, g), and triple-negative (TN) (d, h). P values were calculated using the log-rank test.

Back to article page